Building on past work, Qiagen (QGEN) enters into a collaboration agreement with Eli Lilly (LLY)...

|About: Qiagen N.V. (QGEN)|By:, SA News Editor

Building on past work, Qiagen (QGEN) enters into a collaboration agreement with Eli Lilly (LLY) for the development and commercialization of companion diagnostics for pairing with LLY's investigational and approved medicines across all therapeutic areas. Companion diagnostics unlock a patient's molecular information in order to guide treatment decisions for specific cancers or other diseases. Financial terms of the agreement aren't disclosed.